Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022 at 09:57 AM EDT
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |